For those who are experience with Biotech shares and how Invion develops business/processes.
Lets say that the results that are coming in Quarter 3 are going to be good - wouldn't potential funding bodies/partners already have these results way before us consumers get them??
And IF the results are going to be good wouldn't they already be lining up to strike business/deals partnerships and hence have an effect on the share prices??
Biotech Business Strategies
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.12M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $2.569K | 617.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 29488801 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7213673 | 22 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| IVX (ASX) Chart |